Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy

European Heart Journal - Cardiovascular Pharmacotherapy

6 May 2021
Organised by: Logo
ESC Journals

Abstract

Abstract

Hypokalaemia is common in patients with cardiovascular disease. In this review, we emphasize the importance of tight potassium regulation in patients with cardiovascular disease based on findings from observational studies. To enhance the understanding, we also describe the mechanisms of potassium homeostasis maintenance, the most common causes of hypokalaemia and present strategies for monitoring and management of low potassium levels. We propose elevation of potassium in asymptomatic patients with lower normal concentrations and concurrent cardiovascular disease. These proposals are intended to assist clinicians until more evidence is available.

Contributors

Juan Carlos Kaski
Juan Carlos Kaski

Author

St George's Hospital (London) London , United Kingdom of Great Britain & Northern Ireland

Stefan Agewall
Stefan Agewall

Author

Karolinska Institute Stockholm , Sweden

Juan Tamargo
Juan Tamargo

Author

Complutense University of Madrid Madrid , Spain

ESC 365 is supported by